Amoeba (LTS:0RAE) Notes Receivable: €0.00 Mil (As of Dec. 2025)


LTS:0RAE Amoeba SA LTS:0RAE
28 GF Score
Price €0.76
! 3 Warning Signs
View Full Analysis

What is Amoeba Notes Receivable?

Amoeba LTS:0RAE 28 Notes Receivable is €0.00 Mil as of Dec. 2025. GuruFocus rates LTS:0RAE with a GF Score™ of 28/100. The stock has 3 warning signs investors should review.

Amoeba's Notes Receivable for the quarter that ended in Dec. 2025 was €0.00 Mil.

Amoeba Notes Receivable Historical Data

* Premium members only.

The historical data trend for Amoeba's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amoeba Notes Receivable Chart

Amoeba Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amoeba Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LTS:0RAE
28GF Score
Amoeba SA LTS:0RAE
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amoeba Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
Amoeba (LTS:0RAE) has a Notes Receivable of €0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Amoeba and its competitors.
Is Amoeba's Notes Receivable too high?
Amoeba's current Notes Receivable is €0.00 Mil. Overall, Amoeba has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Amoeba's Notes Receivable compare to CTVA and CF?
Amoeba's Notes Receivable of €0.00 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Agriculture company?
A good Notes Receivable depends on the Agriculture industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Amoeba and its competitors. Amoeba's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amoeba stock overvalued right now?
Amoeba (LTS:0RAE) has a current Notes Receivable of €0.00 Mil. The current Notes Receivable is €0.00 Mil. Amoeba's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Amoeba (LTS:0RAE), the current Notes Receivable is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amoeba Business Description

Other Exchanges ALMIB:FranceA1H:Germany
Address 38 Avenue des Freres Montgolfier, Chassieu, Lyon, FRA, 69680
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
28GF Score

Get the complete analysis for LTS:0RAE

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price